The Vsa proteins modulate susceptibility of Mycoplasma pulmonis to complement killing, hemadsorption, and adherence to polystyrene

Infection and Immunity

Volumn 71, Issue 10, 2003, Pages 5733-5738

  Simmons, Warren L ^a   Dybvig, Kevin ^a  

^a UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; POLYSTYRENE; UNCLASSIFIED DRUG; VARIABLE SURFACE ANTIGEN;

AMINO TERMINAL SEQUENCE; ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIUM ADHERENCE; CARBOXY TERMINAL SEQUENCE; COMPLEMENT SYSTEM; ERYTHROCYTE; GUINEA PIG; HEMADSORPTION; INFECTION SENSITIVITY; MYCOPLASMA PULMONIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; TANDEM REPEAT;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, SURFACE; BACTERIAL ADHESION; BACTERIAL PROTEINS; BASE SEQUENCE; COMPLEMENT SYSTEM PROTEINS; DNA, BACTERIAL; GUINEA PIGS; HEMADSORPTION; HUMANS; MYCOPLASMA; MYCOPLASMA INFECTIONS; POLYSTYRENES; TANDEM REPEAT SEQUENCES;

EID: 0141446123     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.71.10.5733-5738.2003     Document Type: Article

References (50)

1. Alitalo, A., T. Meri, L. Ramo, T. S. Jokiranta, T. Heikkila, I. J. T. Seppala, J. Oksi, M. Viljanen, and S. Meri. 2001. Complement evasion by Borrelia burgdorferi: serum-resistant strains promote C3b inactivation. Infect. Immun. 69:3685-3691.
2. Bhugra, B., L. L. Voelker, N. Zou, H. Yu, and K. Dybvig. 1995. Mechanism of antigenic variation in Mycoplasma pulmonis: interwoven, site-specific DNA inversions. Mol. Microbiol. 18:703-714.
3. Bredt, W., M. Kist, and E. Jacobs. 1981. Phagocytosis and complement action. Isr. J. Med. Sci. 17:637-640.
4. Cartner, S. C., J. R. Lindsey, J. Gibbs-Erwin, G. H. Cassell, and J. W. Simecka. 1998. Roles of innate and adaptive immunity in respiratory mycoplasmosis. Infect. Immun. 66:3485-3491.
5. Cartner, S. C., J. W. Simecka, D. E. Briles, G. H. Cassell, and J. R. Lindsey. 1996. Resistance to mycoplasmal lung disease in mice is a complex genetic trait. Infect. Immun. 64:5326-5331.
6. Cartner, S. C., J. W. Simecka, J. R. Lindsey, G. H. Cassell, and J. K. Davis. 1995. Chronic respiratory mycoplasmosis in C3H/HeN and C57BL/6N mice: lesion severity and antibody response. Infect. Immun. 63:4138-4142.
7. Cassell, G. H. 1982. Derrick Edward Award lecture. The pathogenic potential of mycoplasmas: Mycoplasma pulmonis as a model. Rev. Infect. Dis. 4:S18-34.
8. Cassell, G. H., J. W. A. Clyde, and J. K. Davis. 1985. Mycoplasmal respiratory infections, p. 65-106. In S. Razin and M. F. Barile (ed.), The mycoplasmas: mycoplasma pathogenicity, vol. 4. Academic Press, Orlando, Fla.
9. Citti, C., M. F. Kim, and K. S. Wise. 1997. Elongated versions of Vlp surface lipoproteins protect Mycoplasma hyorhinis escape variants from growth-inhibiting host antibodies. Infect. Immun. 65:1773-1785.
10. Davidson, M. K., J. R. Lindsey, J. K. Davis, R. F. Parker, S. E. Ross, H. L. Watson, J. G. Tully, and G. H. Cassell. 1990. Alternative approach to identihcation of virulence mechanisms of Mycoplasma pulmonis, p. 695-697. In G. Stanek, G. H. Cassell, J. G. Tully, and R. F. Whitcomb (ed.), Recent advances in mycoplasmology, vol. 20. Gustav Fischer Verlag, New York, N.Y.
11. Davidson, M. K., J. R. Lindsey, R. F. Parker, J. G. Tully, and G. H. Cassell. 1988. Differences in virulence for mice among strains of Mycoplasma pulmonis. Infect. Immun. 56:2156-2162.
12. Davis, J. K., R. B. Thorp, R. F. Parker, H. White, D. Dziedzic, J. D'Arcy, and G. H. Cassell. 1986. Development of an aerosol model of murine respiratory mycoplasmosis in mice. Infect. Immun. 54:194-201.
13. Dybvig, K., J. Alderete, H. L. Watson, and G. H. Cassell. 1988. Adsorption of mycoplasma virus P1 to host cells. J. Bacteriol. 170:4373-4375.
14. Dybvig, K., C. T. French, and L. L. Voelker. 2000. Construction and use of derivatives of transposon Tn4001 that function in Mycoplasma pulmonis and Mycoplasma arthritidis. J. Bacteriol. 182:4343-4347.
15. Feeney, K. A., N. Weener, S. M. Gilbert, N. G. Halford, A. S. Tatham, P. R. Shewry, and P. S. Belton. 2003. Molecular structures and interactions of repetitive peptides based on wheat glutenin subunits depend on chain length. Biopolymers 72:123-131.
16. Figueroa, J. E., and P. Densen. 1991. Infectious diseases associated with complement deficiencies. Clin. Microbiol. Rev. 4:359-395.
17. Gardella, R. S., and R. A. DelGiudice. 1983. Hemagglutination, hemadsorption, and hemolysis, p. 379-384. In S. Razin and J. G. Tully (ed.), Methods in mycoplasmology. Academic Press, New York, N.Y.
18. Gumulak-Smith, J., A. Teachman, A. H. Tu, J. W. Simecka, J. R. Lindsey, and K. Dybvig. 2001. Variations in the surface proteins and restriction enzyme systems of Mycoplasma pulmonis in the respiratory tract of infected rats. Mol. Microbiol. 40:1037-1044.
19. Hardy, R. D., H. S. Jafri, K. Olsen, J. Hatfield, J. Iglehart, B. B. Rogers, P. Patel, G. H. Cassell, G, H. McCracken, and O. Ramilo. 2002. Mycoplasma pneumoniae induces chronic respiratory infection, airway hyperreactivity, and pulmonary inflammation: a murine model of infection-associated chronic reactive airway disease. Infect. Immun. 70:649-654.
20. Hardy, R. D., H. S. Jafri, K. Olsen, M. Wordemann, J, Hatfield, B. B. Rogers, P. Patel, L. Duffy, G. H. Cassell, G. H. McCracken, and O. Ramilo, 2001. Elevated cytokine and chemokine levels and prolonged pulmonary airflow resistance in a murine Mycoplasma pneumoniae pneumonia model: a microbiologic, histologic, immunologic, and respiratory plethysmographic profile. Infect. Immun. 69:3869-3876.
21. Jones, T. C., and L. Yang. 1977. Attachment and ingestion of mycoplasmas by mouse macrophages. Am. J. Pathol. 87:331-345.
22. Keystone, E., D. Taylor-Robinson, C. Pope, G, Taylor, and P. Furr, 1978. Effect of inherited deficiency of the fifth component of complement on arthritis induced in mice by Mycoplasma pulmonis. Arthritis Rheum. 21:792-797.
23. Krause, D. C. 1998. Mycoplasma pneumoniae cytadherence: organization and assembly of the attachment organelle. Trends Microbiol. 6:15-18.
24. Krause, D. C., D. K. Leith, and J. B. Baseman. 1983. Reacquisition of specific proteins confers virulence in Mycoplasma pneumoniae. Infect. Immun. 39:830-836.
25. Krause, D. C., D. K. Leith, R. M. Wilson, and J. B. Baseman. 1982. Identification of Mycoplasma pneumoniae proteins associated with hemadsorption and virulence. Infect. Immun. 35:809-817.
26. Krause, D. C., and D. Taylor-Robinson. 1992. Mycoplasmas which infect humans, p. 417-444. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington, D.C.
27. Lindsey, J. R., and G. H. Cassell. 1973. Experimental Mycoplasma pulmonis infection in pathogen-free mice. Am. J. Pathol. 72:63-83.
28. Martin, R. J., H. W. Chu, J. M. Honour, and R. J. Harbeck. 2001. Airway inflammation and bronchial hyperresponsiveness after Mycoplasma pneumoniae infection in a murine model. Am. J. Respir. Cell Mol. Biol. 24:577-582.
29. Neeleman, C., S. P. Geelen, P. C. Aerts, M. R. Daha, T. E. Mollnes, J. J. Roord, G. Posthuma, H. van Dijk, and A. Fleer. 1999. Resistance to both complement activation and phagocytosis in type 3 pneumococci is mediated by the binding of complement regulatory protein factor H. Infect. Immun. 67:4517-4524.
30. Parker, R. F., J. K. Davis, D. K. Blalock, R. B. Thorp, J. W. Simeeka, and G. H. Cassell. 1987. Pulmonary clearance of Mycoplasma pulmonis in C57BL/6N and C3H/HeN mice. Infect. Immun. 55:2631-2635.
31. Parker, R. F., J. K. Davis, G. H. Cassell, H. White, D. Dziedzic, D. K. Blalock, R. B. Thorp, and J. W. Simecka. 1989. Short-term exposure to nitrogen dioxide enhances susceptibility to murine respiratory mycoplasmosis and decreases intrapulmonary killing of Mycoplasma pulmonis. Am. Rev. Respir. Dis. 140:502-512.
32. Rautemaa, R., G. A. Jarvis, P. Marnila, and S. Meri. 1998. Acquired resistance of Escherichia coli to complement lysis by binding of glycophosphoinositol-anchored protectin (CD59). Infect. Immun. 66:1928-1933.
33. Regal, J. F. 1997. Role of the complement system in pulmonary disorders. Immunopharmacology 38:17-25.
34. Shen, X., J. Gumulak, H. Yu, C. T. French, N. Zou, and K. Dybvig. 2000. Gene rearrangements in the vsa locus of Mycoplasma pulmonis. J. Bacteriol. 182:2900-2908.
35. Simecka, J. W., J. K. Davis, M. K. Davidson, S. E. Ross, C. T. K.-H. Städtlander, and G. H. Cassell. 1992. Mycoplasma diseases of animals, p. 391-415. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathology. American Society for Microbiology, Washington, D.C.
36. Simecka, J. W., P. Patel, J. K. Davis, and G. H. Cassell. 1989. Upper respiratory tract is the major site of antibody production in mycoplasmal induced chronic respiratory disease. Reg. Immunol. 2:385-389.
37. Simmons, W. L., C. Zuhua, J. I. Glass, J. W. Simecka, G. H. Cassell, and H. L. Watson. 1996. Sequence analysis of the chromosomal region around and within the V-1-encoding gene of Mycoplasma pulmonis: evidence for DNA inversion as a mechanism for V-1 variation. Infect. Immun. 64:472-479.
38. Sitaraman, R., A. M. Denison, and K. Dybvig. 2002. A unique, bifunctional site-specific DNA recombinase from Mycoplasma pulmonis. Mol. Microbiol. 46:1033-1040.
39. Stadtlander, C. T., H. L. Watson, J. W. Simecka, and G. H. Cassell. 1991. Cytopathic effects of Mycoplasma pulmonis in vivo and in vitro. Infect. Immun. 59:4201-4211.
40. Talkington, D. F., M. T. Fallon, H. L. Watson, R. K. Thorp, and G. H. Cassell. 1989. Mycoplasma pulmonis V-1 surface protein variation: occurrence in vivo and association with lung lesions. Microb. Pathog. 7:429-436.
41. Taylor-Robinson, D., H. U. Schorlemmer, P. M. Furr, and A. C. Allison. 1978. Macrophage secretion and the complement cleavage product C3a in the pathogenesis of infections by mycoplasmas and L-forms of bacteria and in immunity to these organisms. Clin. Exp. Immunol. 33:486-494.
42. Teachman, A. M., C. T. French, H. Yu, W. L. Simmons, and K. Dybvig. 2002. Gene transfer in Mycoplasma pulmonis. J. Bacteriol. 184:947-951.
43. Towbin, H., T. Staehelin, and J. Gordon. 1979. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76:4350-4354.
44. Watson, H. L., D. K. Blalock, and G. H. Cassell. 1988. Characterization of the variable V-1 antigen of Mycoplasma pulmonis, p. 529-534. In G. Stanek, G. H. Cassell, J. G. Tully, and R. F. Whitcomb (ed.), Recent advances in mycoplasmology, vol. 20. Gustav Fischer Verlag, New York, N.Y.
45. Watson, H. L., D. K. Blalock, and G. H. Cassell. 1990. Relationship of hydrophobicity of the V-1 antigen of Mycoplasma pulmonis to adherence. Rec. Adv. Mycoplasmol. 20:650-654.
46. Watson, H. L., K. Dybvig, D. K. Blalock, and G. H. Cassell. 1989. Subunit structure of the variable V-1 antigen of Mycoplasma pulmonis. Infect. Immun. 57:1684-1690.
47. Watson, H. L., L. S. McDaniel, D. K. Blalock, M. T. Fallon, and G. H. Cassell. 1988. Heterogeneity among strains and a high rate of variation within strains of a major surface antigen of Mycoplasma pulmonis. Infect. Immun. 56:1358-1363.
48. Watson, H. L., X. Zheng, and G. H. Cassell. 1993. Structural variations and phenotypic switching of mycoplasmal antigens. Clin. Infect. Dis. 17:S183-S186.
49. Wise, K. S., D. Yogev, and R. Rosengarten. 1992. Antigenic variation, p. 473-490. In J. Maniloff, R. N. McElhaney, L. R. Finch, and J. B. Baseman (ed.), Mycoplasmas: molecular biology and pathogenesis. American Society for Microbiology, Washington. D.C.
50. Yano, T., Y. Ichikawa, S. Komatu, S. Arai, and K. Oizumi. 1994. Association of Mycoplasma pneumoniae antigen with initial onset of bronchial asthma. Am. J. Respir. Crit. Care Med. 149:1348-1353.